APA (7th ed.) Citation

López, F. A., & Leroux, J. R. (2013). Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: A focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges. Attention deficit and hyperactivity disorders, 5(3), 249-265. https://doi.org/10.1007/s12402-013-0106-x

Chicago Style (17th ed.) Citation

López, Frank A., and Jacques R. Leroux. "Long-acting Stimulants for Treatment of Attention-deficit/hyperactivity Disorder: A Focus on Extended-release Formulations and the Prodrug Lisdexamfetamine Dimesylate to Address Continuing Clinical Challenges." Attention Deficit and Hyperactivity Disorders 5, no. 3 (2013): 249-265. https://doi.org/10.1007/s12402-013-0106-x.

MLA (9th ed.) Citation

López, Frank A., and Jacques R. Leroux. "Long-acting Stimulants for Treatment of Attention-deficit/hyperactivity Disorder: A Focus on Extended-release Formulations and the Prodrug Lisdexamfetamine Dimesylate to Address Continuing Clinical Challenges." Attention Deficit and Hyperactivity Disorders, vol. 5, no. 3, 2013, pp. 249-265, https://doi.org/10.1007/s12402-013-0106-x.